Feb 6, 2023 | Lung Cancer
1b) Be sure to check out (and earn even MORE 🆓CE/#CME credit from my colleague @PatelOncology 's introduction to contemporary #ES_SCLC management at https://t.co/hqEQbEqvBg.We strive to keep our 🫁 med colleagues up to date on oncology issues!— pulmmed_ce...
Jan 31, 2023 | Lung Cancer
2a) I am Dr. Sandip Patel @PatelOncology, Professor in Medical Oncology from @UCSDCancer. @nicogirardcurie (to follow) and I will be covering Optimal Immuno-Oncologic Management of Extensive-Stage Small Cell Lung Cancer & Strategies to Develop Individualized...
Jan 3, 2023 | Lung Cancer
2) I am Dr. Aakash Desai (@ADesaiMD) from @MayoHemOnc @MayoCancerCare @HemOncFellows @Oncoalert and now we are covering @myESMO #ESMOImmuno22 updates/review on “Biomarker Targeted therapies” in #LCSM! pic.twitter.com/43wAJCH3gR— pulmmed_ce (@Pulmmed_CE) January...
Nov 1, 2022 | Lung Cancer
2) Now we are covering @myESMO #ESMO22 updates on #ADCs in development for #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD) from @IEOufficiale, Milan in Italy 🇮🇹 pic.twitter.com/GWgziWfkc7— pulmmed_ce (@Pulmmed_CE) November 2, 2022 3b) This...
Oct 24, 2022 | Lung Cancer
2) In this program we are covering @myESMO #ESMO22 updates on #HER2 mutant #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD) from @IEOufficiale, Milan in Italy 🇮🇹 pic.twitter.com/8Rm1MxsPC7— pulmmed_ce (@Pulmmed_CE) October 26, 2022 3b) This...